InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: None

Sunday, 05/13/2007 3:09:23 AM

Sunday, May 13, 2007 3:09:23 AM

Post# of 1367

Gamida Cell and NovaThera to collaborate on lung repair
The companies will develop cell therapeutic treatments for lung repair and regeneration.

http://www.globes.co.il/serveen/globes/docview.asp?did=1000210051&fid=942

[I do not follow stem cell company very closely but if I had to point to an Israeli one it would be Gamida Cell.]

Gali Weinreb 9 May 07 13:21
Israeli start-up Gamida Cell Ltd. and NovaThera Ltd. of the UK have signed a cooperation agreement for the development of cell therapeutic treatments for lung repair and regeneration. The companies will pool technology and expertise and work together with the clinical team at Papworth Hospital in Cambridge towards advancing cell therapy approaches for treating lung disease.

Gamida Cell CEO Dr. Yael Margolin said, “This collaboration is in line with our strategy to partner with selected companies focused on developing therapeutics for life threatening illnesses and to help bring these products to market.”

NovaThera, owned by London’s Imperial College, specializes in pioneering applications of biomaterials and stem cell biology for regenerative medicine and tissue engineering to provide innovative therapeutic solutions. Gamida Cell develops therapeutics using proprietary technologies that expand populations of hematopoietic stem/progenitor cells such as those derived from cord blood (not the controversial embryonic stem cells), for the treatment of hematological diseases as well as for tissue regeneration applications.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.